Minimally Invasive Surgical Therapy for BPH

Stopped early · Phase 3

Conditions studied: Benign Prostatic Hyperplasia

In brief

The primary objective of this randomized clinical trial is to determine the efficacy and safety of three treatments for benign prostatic hyperplasia (BPH): transurethral needle ablation (TUNA), transurethral microwave therapy (TUMT), and medical therapy with alfuzosin and finasteride.

Key facts

Study ID

NCT00064649

Run by

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

People needed

49

Starts

2004-04-01

Expected to finish

2006-06-01

Last updated by the study team

2010-01-14

Who can join

Age: 50 and older. Sex: male. Healthy volunteers: not accepted.

Where it is running

• University of Colorado Health Sciences Center — Denver, Colorado, United States
• Northwestern University — Chicago, Illinois, United States
• Mayo Clinic — Rochester, Minnesota, United States
• Columbia University — New York, New York, United States
• University of Texas Southwestern Medical Center — Dallas, Texas, United States
• Baylor College of Medicine — Houston, Texas, United States
• Medical College of Wisconsin — Milwaukee, Wisconsin, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.